Cost‐effectiveness of electronic‐ and clinician‐delivered screening, brief intervention and referral to treatment for women in reproductive health centers
Abstract
Aims: To determine the cost‐effectiveness of electronic‐ and clinician‐delivered SBIRT (Screening, Brief Intervention and Referral to Treatment) for reducing primary substance use among women treated in reproductive health centers. Design: Cost‐effectiveness analysis based on a randomized controlled trial. Setting: New Haven, CT, USA. Participants: A convenience sample of 439 women seeking routine care in reproductive health centers who used cigarettes, risky amounts of alcohol, illicit drugs or misused prescription medication. Interventions: Participants were randomized to enhanced usual care (EUC, n = 151), electronic‐delivered SBIRT (e‐SBIRT, n = 143) or clinician‐delivered SBIRT (SBIRT, n = 145). Measurements: The primary outcome was days of primary substance abstinence during the 6‐month follow‐up period. To account for the possibility that patients might substitute a different drug for their primary substance during the 6‐month follow‐up period, we also considered the number of days of abstinence from all substances. Incremental cost‐effectiveness ratios and cost‐effectiveness acceptability curves determined the relative cost‐effectiveness of the three conditions from both the clinic and patient perspectives. Findings: From a health‐care provider perspective, e‐SBIRT is likely (with probability greater than 0.5) to be cost‐effective for any willingness‐to‐pay value for an additional day of primary‐substance abstinence and an additional day of all‐substance abstinence. From a patient perspective, EUC is most likely to be the cost‐effective intervention when the willingness to pay for an additional day of abstinence (both primary‐substance and all‐substance) is less than $0.18 and e‐SBIRT is most likely to be the cost‐effective intervention when the willingness to pay for an additional day of abstinence (both primary‐substance and all‐substance) is greater than $0.18. Conclusions: e‐SBIRT could be a cost‐effective approach, from both health‐care provider and patient perspectives, for use in reproductive health centers to help women reduce substance misuse.Keywords
This publication has 35 references indexed in Scilit:
- Conducting economic evaluations of screening and brief intervention for hazardous drinking: Methods and evidence to date for informing policyDrug and Alcohol Review, 2010
- Motivational interviewing for smoking cessation: A meta-analytic review.Journal of Consulting and Clinical Psychology, 2010
- Evaluation of the Washington State Screening, Brief Intervention, and Referral to Treatment ProjectMedical Care, 2010
- A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users.Journal of Consulting and Clinical Psychology, 2009
- Community program therapist adherence and competence in motivational enhancement therapyDrug and Alcohol Dependence, 2008
- Methodological Issues in Alcohol Screening and Brief Intervention ResearchSubstance Abuse, 2007
- Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics.Journal of Consulting and Clinical Psychology, 2007
- Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness studyDrug and Alcohol Dependence, 2006
- Missing.... presumed at random: cost‐analysis of incomplete dataHealth Economics, 2002
- The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties.Journal of Consulting and Clinical Psychology, 2000